TG Therapeutics to Host Conference Call on Second Quarter 2024 Financial Results and Business Update

Go back to TG Therapeutics to Host Conference Call on Second Quarter 2024 Financial Results and Business Update

TG Therapeutics (TGTX) PT Raised to $30 at JPMorgan

August 7, 2024 6:17 AM EDT

JPMorgan analyst Eric Joseph raised the price target on TG Therapeutics (NASDAQ: TGTX) to $30.00 (from $26.00) while maintaining a Overweight rating.

The analyst comments "Following TGs 2Q results and conference call we are updating our model, with takeaways from the call... More